No data to
display.
Moderna, Inc. revenue decreases to $1,831 million in quarter ended Sep 30, 2023 from previous quarter
By NewsInMinutes on Nov 04, 2023 | 05:34 AM IST
| Current Reporting | Revenue | Net Income | Profit/Loss |
|---|---|---|---|
| Sep 2023 | $1,831 million | $3,630 million | loss |
| Jun 2023 | $344 million | $1,380 million | loss |
| Mar 2023 | $1,862 million | $79 million | profit |
Moderna, Inc. [MRNA] has reported $3,630 million loss for the fiscal quarter ending Sep 30, 2023.
Revenue for the quarter was $1,831 million with operating income of $2,012 million.
The Cambridge, Massachusetts (MA)-based company operating in the biological products, except diagnostic substances sector has total shareholders equity of $13,455 million.
Also read:
This is a developing story. Click here to receive updates.
------------
NewsInMinutes, an offering of 10kInfo, Inc., brings you news on the latest regulatory filings. Subscribe to additional news alerts here.